Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy
NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18...
Plume Appoints Lorie Boyd as Chief People Officer
Boyd brings deep HR and workforce management experience from Turo and Zendesk to help Plume scale through next phase of global growth PALO ALTO, Calif., Dec. 12, 2025 /PRNewswire/ -- Plume, a leader in cloud-managed Wi-Fi, security, and smart home...
Robo.ai Inc. Reaches a $180 Million Financing Agreement with ATW Partners
DUBAI, UAE, Dec. 12, 2025 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO), a technology platform dedicated to "AI, Smart Device and Smart Asset", today announced that it has entered into definitive agreements with ATW Partners (www.atwpartners.com) for...
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy
NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18...
Holiday Demand Marks Monport's Mission to Support Expanding Craft on Custom Laser Engraving
NEW YORK, Dec. 12, 2025 /PRNewswire/ -- The holiday season has sparked renewed interest in the tools behind today's personalization boom, with many creators seeking reliable CO2 laser cutter engraver and fiber laser engraving systems to meet rising...
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)
Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD inhibitor with IND clearance granted in 2023. The...
WOVEN WOVEN ANSWERS PARENTAL DEMAND: LAUNCHES HIGHLY ANTICIPATED 3KG WEIGHTED BLANKET COLLECTION TO SUPPORT GROWING CHILDREN
SYDNEY, Dec. 12, 2025 /PRNewswire/ -- woven woven, the multi-award-winning Australian start-up and pioneering disruptor in children's wellness, today announced the expansion of its acclaimed collection with the launch of a new, highly demanded 3.0kg...
Formula 1 Etihad Airways Abu Dhabi Grand Prix brings 339,000 fans to Yas Island
ABU DHABI, UAE, Dec. 12, 2025 /PRNewswire/ -- Ethara, the organisers of the Formula 1® Etihad Airways Abu Dhabi Grand Prix, announced that the 2025 race week broke attendance records with a combined total of 339,000 fans across events....
Chindata and HEC Deepen Collaboration with AI Compute Projects in Shaoguan and Ulanqab
BEIJING, Dec. 12, 2025 /PRNewswire/ -- In recent weeks, Chindata Group has announced two significant partnerships with HEC Group, advancing coordinated development across Shaoguan in Guangdong Province and Ulanqab in Inner Mongolia. Together, the...
Sunwoda's 314Ah Cell is Now the World's First Battery Product Certified by EPD International
SHENZHEN, China, Dec. 12, 2025 /PRNewswire/ -- Sunwoda (Stock Code: 300207), a global full-scenario energy storage solution provider, announced that its 314Ah energy storage cell has officially been certified by EPD International, making it the...